SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 225 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $411,000 | +0.5% | 262,020 | +28.7% | 0.04% | +8.6% |
| Q2 2022 | $409,000 | -56.4% | 203,663 | +79.6% | 0.04% | -47.0% |
| Q1 2021 | $938,000 | -47.5% | 113,385 | -56.7% | 0.07% | -65.8% |
| Q4 2020 | $1,787,000 | +489.8% | 261,795 | +191.7% | 0.19% | +565.5% |
| Q4 2019 | $303,000 | +163.5% | 89,749 | +108.5% | 0.03% | +314.3% |
| Q2 2019 | $115,000 | -16.1% | 43,041 | +49.4% | 0.01% | -12.5% |
| Q1 2019 | $137,000 | -18.0% | 28,817 | -58.5% | 0.01% | -11.1% |
| Q4 2018 | $167,000 | -28.9% | 69,509 | +30.4% | 0.01% | -35.7% |
| Q3 2018 | $235,000 | +46.9% | 53,307 | +71.5% | 0.01% | +55.6% |
| Q1 2018 | $160,000 | +116.2% | 31,083 | -28.3% | 0.01% | +125.0% |
| Q3 2017 | $74,000 | +164.3% | 43,348 | +207.7% | 0.00% | 0.0% |
| Q2 2017 | $28,000 | – | 14,090 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |